TMHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Taylor Morrison Home Corp (TMHC) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance shows declining growth trends, and there are no strong positive catalysts or trading signals to suggest immediate upside potential. A hold position is recommended until clearer growth signals or catalysts emerge.
The technical indicators for TMHC are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 43.697, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 58.844, with resistance at 60.349 and support at 57.339.
The company's focus on active adult and move-up buyers, who have shown resilience in a volatile mortgage rate environment, is a potential strength.
The company's Q4 2025 financials show significant declines in revenue (-10.90% YoY), net income (-28.23% YoY), EPS (-23.48% YoY), and gross margin (-8.36% YoY). Technical indicators are bearish, and there are no recent trading signals or significant insider/hedge fund activity. Additionally, the stock has a 60% chance of declining in the next day (-1.13%) and month (-2.68%).
In Q4 2025, Taylor Morrison reported declining financial performance, with revenue dropping to $2.1 billion (-10.90% YoY), net income decreasing to $174 million (-28.23% YoY), EPS falling to 1.76 (-23.48% YoY), and gross margin contracting to 22.04% (-8.36% YoY).
Analysts have mixed ratings with recent price targets ranging from $62 to $95. Truist initiated coverage with a Buy rating and an $85 price target, citing long-term growth potential. RBC Capital raised its price target to $68 from $62 after a Q4 earnings beat but remains cautious about demand and margins. Barclays lowered its price target slightly to $70, maintaining an Overweight rating. Overall, analysts see potential upside but acknowledge challenges in the housing market.
